Table 3 Estimation of cumulative incidence (risk) of current parasitaemia after chloroquine therapy and malaria by P. vivax adjusted for the concentration of chloroquine + desethylchloroquine (CQ + DCQ) in blood on the day of therapeutic failure (TF)
From: Resistance of infection by Plasmodium vivax to chloroquine in Bolivia
Day | Number of patients | TF/CQ + DCQ >100 ng/dl | Censored | Failure cumulative incidence |
|---|---|---|---|---|
0 | 96 | 0 | 0 | 0 |
2 | 96 | 0 | 3 | 0 |
3 | 93 | 0 | 0 | 0 |
7 | 93 | 1 | 1 | 0.01 |
14 | 91 | 0 | 0 | 0.01 |
21 | 91 | 1 | 0 | 0.022 |
28 | 90 | 4 | 0 | 0.065 |
Total | 86 | 6 | 4 | (95% CI 0.029–0.139) |